0001162956-14-000005.txt : 20141120 0001162956-14-000005.hdr.sgml : 20141120 20141120171021 ACCESSION NUMBER: 0001162956-14-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141118 FILED AS OF DATE: 20141120 DATE AS OF CHANGE: 20141120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERMILLION, INC. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAFRANCE JAMES T CENTRAL INDEX KEY: 0001162956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 141239709 MAIL ADDRESS: STREET 1: 1910 INNOVATION PARK DR CITY: TUCSON STATE: AZ ZIP: 85737 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-11-18 0 0000926617 VERMILLION, INC. VRML 0001162956 LAFRANCE JAMES T 12117 BEE CAVES RD BUILDING THREE, SUITE 100 AUSTIN TX 78738 1 1 0 0 President & Chief Exec Officer Common Stock 2014-11-18 4 P 0 29940 1.4 A 38440 D Common Stock 2014-11-19 4 P 0 11675 1.5 A 50115 D The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.26 to $1.50. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.44 to $1.51. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ James LaFrance 2014-11-20